市场快照
| Study Period: | 2017-2025 |
| Base Year: | 2021 |
| Fastest Growing Market: | Asia Pacific |
| Largest Market: | North America |
| CAGR: | 9.2 % |
|
Need a report that reflects how COVID-19 has impacted this market and its growth?
市场概况
在预测期内，研究的免疫血液学市场预计将以 9.2% 的预期复合年增长率增长。
推动免疫血液学市场增长的主要驱动力是全球创伤病例和血液疾病的日益流行。预计技术进步的不断增加以及主要参与者对研发活动的投资增加将推动市场。根据健康指标与评估研究所的数据，2019 年血红蛋白病和溶血性贫血的发病率估计为每 100,000 人中有 580 人。癌症患者在手术和非手术治疗期间需要输血和血液成分。根据世界卫生组织的数据，癌症是导致死亡的主要原因，2018 年全球有 960 万人死亡。因此，鉴于上述因素，免疫血液学市场预计将在预测期内显着增长
报告范围
根据报告的范围，免疫血液学是指研究血细胞上存在的抗原和血浆中存在的抗体之间发生的反应。对于患有自身免疫性溶血性贫血等血液疾病的患者，可以使用广泛的免疫血液学技术来识别和解决这些患者的诊断问题。
| By Products | |
| Immunohematology Analyzers | |
| Immunohematology Reagents |
| By Application | |
| Blood Typing | |
| Antibody Screening |
| By End User | |
| Hospitals | |
| Diagnostic Laboratories | |
| Others |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
主要市场趋势
免疫血液学分析仪部分预计将在预测期内增加
技术的进步导致了自动化免疫血液分析仪的发展，这些分析仪更精确，提供准确的结果，消耗更少的试剂并有助于顺畅的工作流程。一些分析仪还在屏幕上显示即时数字结果，以便对血液进行快速筛查和分类。自动化提高了测试的客观性和可重复性，减少了人为错误，并有助于测试、试剂和过程的记录和可追溯性。大多数主要参与者都参与了在市场上推出新的免疫血液分析仪。例如，2019 年，Alcor Scientific 推出了 miniiSED，这是一种自动沉降速率分析仪，以毫米/小时为单位报告沉降速率。2019 年，Sight Diagnostics 推出了 Olo，一种定量、多参数、用于临床实验室的自动血液分析仪。因此，鉴于上述因素，免疫血液分析仪细分市场预计将在预测期内出现显着增长。
To understand key trends, Download Sample Report
北美在人工胰腺设备系统市场占有主导地位，预计在预测期内也将大幅增长
先进的医疗保健基础设施、血库设施的可用性以及创伤和目标疾病发病率的增加是北美免疫血液学市场增长的主要驱动力。根据美国红十字会的数据，美国每年有近 2100 万种血液成分被输注。根据健康指标和评估研究所的数据，2019 年美国镰状细胞性贫血的患病率估计为 38,464。根据美国癌症协会的《2020 年癌症事实和数据》，美国估计共有 178,520 人预计2020年将被诊断出患有白血病、淋巴瘤或骨髓瘤，预计新发白血病、淋巴瘤和骨髓瘤病例将占估计的1806例的9.9%，
To understand geography trends, Download Sample Report
竞争格局
免疫血液学市场竞争激烈，由主导市场的重要主要参与者组成。研究市场的主要参与者是 Bio-Rad 实验室，Inc，Abbott Laboratories，Merck KGaA，Beckman Coulter，Inc.，Thermo Fisher Scientific，F.Hoffmann La-Roche Ltd，Immucor，Inc.，Grifols SA 等等。主要参与者正在发展各种战略，例如合作和收购，并积极参与市场新产品的推出。例如，2020 年 5 月，Beckman Coulter, Inc. 在美国推出了 DxH 690T 台式血液分析仪。
Table of Contents
-
1. INTRODUCTION
-
1.1 Study Assumptions and Market Definition
-
1.2 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Increasing Incidence of Trauma and Immunohematological disorders
-
4.2.2 Technological Advancements for Development of New Products
-
-
4.3 Market Restraints
-
4.3.1 High Cost of Products
-
4.3.2 Lack of Skilled Personnel
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Products
-
5.1.1 Immunohematology Analyzers
-
5.1.2 Immunohematology Reagents
-
-
5.2 By Application
-
5.2.1 Blood Typing
-
5.2.2 Antibody Screening
-
-
5.3 By End User
-
5.3.1 Hospitals
-
5.3.2 Diagnostic Laboratories
-
5.3.3 Others
-
-
5.4 Geography
-
5.4.1 North America
-
5.4.1.1 United States
-
5.4.1.2 Canada
-
5.4.1.3 Mexico
-
-
5.4.2 Europe
-
5.4.2.1 Germany
-
5.4.2.2 United Kingdom
-
5.4.2.3 France
-
5.4.2.4 Italy
-
5.4.2.5 Spain
-
5.4.2.6 Rest of Europe
-
-
5.4.3 Asia-Pacific
-
5.4.3.1 China
-
5.4.3.2 Japan
-
5.4.3.3 India
-
5.4.3.4 Australia
-
5.4.3.5 South Korea
-
5.4.3.6 Rest of Asia-Pacific
-
-
5.4.4 Middle-East and Africa
-
5.4.4.1 GCC
-
5.4.4.2 South Africa
-
5.4.4.3 Rest of Middle-East and Africa
-
-
5.4.5 South America
-
5.4.5.1 Brazil
-
5.4.5.2 Argentina
-
5.4.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Bio-Rad Laboratories, Inc.
-
6.1.2 Immucor, Inc.
-
6.1.3 Grifols S.A.
-
6.1.4 Becton Dickinson and Company
-
6.1.5 Beckman Coulter Inc. (Danaher Corporation)
-
6.1.6 Siemens Healthineers
-
6.1.7 Thermo Fisher Scientific
-
6.1.8 Abbott Laboratories
-
6.1.9 Merck KGaA
-
6.1.10 F. Hoffmann La-Roche Ltd
-
*List Not Exhaustive -
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Immunohematology Market market is studied from 2017 - 2025.
What is the growth rate of Immunohematology Market ?
The Immunohematology Market is growing at a CAGR of 9.2% over the next 5 years.
Which region has highest growth rate in Immunohematology Market ?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Immunohematology Market ?
North America holds highest share in 2021.
Who are the key players in Immunohematology Market ?
Grifols S.A. , Immucor Inc. , Thermo Fisher Scientific , Merck KGaA , Abbott Laboratories are the major companies operating in Immunohematology Market .
